Saturday May 19th
 |
08:30 am 10:30 am |
•
•
•
• |
Academic Session IV Metabolic syndrome, worldwide concern Chair: Hermans Michel (Belgium) Prevalence of metabolic syndrome in Middle East Al-Rubeaan Khalid (Saudi Arabia) Metabolic syndrome and diabetes in Russia Susekov Andrey V. (Russia) Prevalence of metabolic syndrome in Latin America Calvo Carlos (Chile) Cardiovascular risk and metabolic syndrome in Morocco and Maghreb Bennis Ahmed (Morocco) |
10:30 am 11:00 am |
|
Coffee Break |
11:00 am 12:30 pm |
•
•
• |
Academic Session V Advances in the clinical management of lipids and glucose for the prevention of CVD in metabolic diseases Chair: Fernandez-Cruz Arturo (Spain) Atherogenic dyslipidemia: the PROCAM experience Assmann Gerd (Germany) Advances in the clinical management of HDL Zambon Alberto (Italy) Non-pharmacological treatment in children with metabolic syndrome. Does it work ? What is the role of genes? Ceska Richard (Czech Republic) |
12:30 pm 02:00 pm |
|
Lunch |
02:00 pm 04:00 pm |
•
• |
R3i Symposium Residual risk reduction initiative meeting Chair: Sadikot Shaukat M. (India) REALIST Study: link between atherogenic dyslipidemia and macrovascular complications of diabetes type II HERMANS Michel (Belgium) REALIST Study: link between atherogenic dyslipidemia and microvascular complications of diabetes type II Fruchart Jean-Charles (France) R3i round table |
|
|
END OF THE CONGRESS |
